Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Gassmann

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Journal of Translational Medicine|April 28, 2016
Changing R&D models in research-based pharmaceutical companiesAlexander Schuhmacher, Oliver Gassmann, Markus Hinder
Drug Discovery Today|July 20, 2019
The Art of Virtualizing Pharma R&DAlexander Schuhmacher, Oliver Gassmann, Michael Kuss, et al.
Drug Discovery Today|August 4, 2020
The present and future of project management in pharmaceutical R&DAlexander Schuhmacher, Oliver Gassmann, Markus Hinder, et al.
Journal of Translational Medicine|May 10, 2018
Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?Alexander Schuhmacher, Oliver Gassmann, Nigel McCracken, et al.
Drug Discovery Today|August 3, 2024
Comparative analysis of FDA approvals by top 20 pharma companies (2014-2023)Alexander Schuhmacher, Oliver Gassmann, Markus Hinder, et al.
Drug Discovery Today|July 30, 2013
Models for open innovation in the pharmaceutical industryAlexander Schuhmacher, Paul-Georg Germann, Henning Trill, et al.
Drug Discovery Today|November 15, 2011
Getting the most out of your IP--patent management along its life cycleMartin A Bader, Oliver Gassmann, Nicole Ziegler, et al.
Drug Discovery Today|June 1, 2022
Open innovation: A paradigm shift in pharma R&D?Alexander Schuhmacher, Oliver Gassmann, Doria Bieniok, et al.
Drug Discovery Today|July 6, 2021
Systematic risk identification and assessment using a new risk map in pharmaceutical R&DAlexander Schuhmacher, Clara Brieke, Oliver Gassmann, et al.
Drug Discovery Today|April 19, 2026
New perspectives for better R&D performance: lessons learned from leading pharma companiesAlexander Schuhmacher, Oliver Gassmann, Sara Knapp, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Journal of Translational Medicine|April 28, 2016
Changing R&D models in research-based pharmaceutical companiesAlexander Schuhmacher, Oliver Gassmann, Markus Hinder
Drug Discovery Today|July 20, 2019
The Art of Virtualizing Pharma R&DAlexander Schuhmacher, Oliver Gassmann, Michael Kuss, et al.
Drug Discovery Today|August 4, 2020
The present and future of project management in pharmaceutical R&DAlexander Schuhmacher, Oliver Gassmann, Markus Hinder, et al.
Journal of Translational Medicine|May 10, 2018
Open innovation and external sources of innovation. An opportunity to fuel the R&D pipeline and enhance decision making?Alexander Schuhmacher, Oliver Gassmann, Nigel McCracken, et al.
Drug Discovery Today|August 3, 2024
Comparative analysis of FDA approvals by top 20 pharma companies (2014-2023)Alexander Schuhmacher, Oliver Gassmann, Markus Hinder, et al.
Drug Discovery Today|July 30, 2013
Models for open innovation in the pharmaceutical industryAlexander Schuhmacher, Paul-Georg Germann, Henning Trill, et al.
Drug Discovery Today|November 15, 2011
Getting the most out of your IP--patent management along its life cycleMartin A Bader, Oliver Gassmann, Nicole Ziegler, et al.
Drug Discovery Today|June 1, 2022
Open innovation: A paradigm shift in pharma R&D?Alexander Schuhmacher, Oliver Gassmann, Doria Bieniok, et al.
Drug Discovery Today|July 6, 2021
Systematic risk identification and assessment using a new risk map in pharmaceutical R&DAlexander Schuhmacher, Clara Brieke, Oliver Gassmann, et al.
Drug Discovery Today|April 19, 2026
New perspectives for better R&D performance: lessons learned from leading pharma companiesAlexander Schuhmacher, Oliver Gassmann, Sara Knapp, et al.
Pageof 3